Neurochemical profiles of some novel psychoactive substances.

@article{Iversen2013NeurochemicalPO,
  title={Neurochemical profiles of some novel psychoactive substances.},
  author={L. Iversen and S. Gibbons and R. Treble and Vincent Setola and X. Huang and B. Roth},
  journal={European journal of pharmacology},
  year={2013},
  volume={700 1-3},
  pages={
          147-51
        }
}
  • L. Iversen, S. Gibbons, +3 authors B. Roth
  • Published 2013
  • Chemistry, Medicine
  • European journal of pharmacology
    • Fourteen substances from the class of drugs sometimes known as "legal highs" were screened against a battery of human receptors in binding assays, and their potencies as inhibitors of monoamine uptake determined in functional in vitro assays. Thirteen of the test substances acted as inhibitors of monoamine uptake at submicromolar concentrations, including 9 potent inhibitors of the dopamine transporter (DAT), 12 potent inhibitors of the norepinephrine transporter (NET) and 4 potent inhibitors… CONTINUE READING
    View on PubMed
    europepmc.org
    131 Citations
    Highly Influencial Citations
    15
    Background Citations
    65
    Methods Citations
    3
    Results Citations
    15

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    131 Citations
    Citation Type

    Citation Type

    Neurochemical binding profiles of novel indole and benzofuran MDMA analogues
    • 13
    • Highly Influenced
    Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones
    • 112
    • Highly Influenced
    • PDF
    New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems
    • 39
    Monoamine Transporter and Receptor Interaction Profiles of Synthetic Cathinones
    • 4
    The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
    Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
    • 59
    • Highly Influenced
    • PDF
    Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
    • 139
    • Highly Influenced
    Designer psychostimulants: Pharmacology and differences
    • 53
    Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    • 128
    • PDF
    2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors
    • 2
    • Highly Influenced

    References

    SHOWING 1-10 OF 45 REFERENCES
    The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
    • 224
    N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity
    • 262
    • PDF
    Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil
    • 166
    • PDF
    Interaction of mephedrone with dopamine and serotonin targets in rats
    • 107
    • PDF
    Monoamine transporters and psychostimulant drugs.
    • 410
    The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
    • 341
    • PDF
    Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors
    • 97
    • PDF
    3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
    • 257
    • PDF
    Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro
    • 116
    • PDF
    Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines
    • 158